138 related articles for article (PubMed ID: 1376846)
41. [Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].
Vogt M; Motz W; Strauer BE
Arzneimittelforschung; 1994 Dec; 44(12):1321-8. PubMed ID: 7848351
[TBL] [Abstract][Full Text] [Related]
42. [Clinical trial with isradipine in the treatment of mild and moderate arterial hypertension].
Miguel JM; Nunes AC; Gonçalves FR; Pêgo GM
Rev Port Cardiol; 1991 Dec; 10(12):931-9. PubMed ID: 1839656
[TBL] [Abstract][Full Text] [Related]
43. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
Christensen HR; Kampmann JP; Simonsen K
J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
[TBL] [Abstract][Full Text] [Related]
44. Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
Casagrande P; Valvo E; Bedogna V; Loschiavo C; Giorgetti P; Graziani MS; Maschio G
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):79-83. PubMed ID: 2307549
[TBL] [Abstract][Full Text] [Related]
45. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
Burger KJ; Dehner R
Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
[TBL] [Abstract][Full Text] [Related]
46. Effects of calcium channel blockers on cardiovascular responses to smoking in normotensive and hypertensive smokers.
Fogari R; Zoppi A; Malamani GD; Corradi L
Int J Clin Pharmacol Res; 1992; 12(2):81-8. PubMed ID: 1428302
[TBL] [Abstract][Full Text] [Related]
47. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
[TBL] [Abstract][Full Text] [Related]
48. Renal and hemodynamic effects of isradipine in essential hypertension.
Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
[TBL] [Abstract][Full Text] [Related]
49. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
Persson B; Wysocki M; Andersson OK
J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
[TBL] [Abstract][Full Text] [Related]
50. Isradipine in the treatment of hypertensive crisis in ambulatory patients.
Saragoça MA; Portela JE; Plavnik F; Ventura RP; Lotaif L; Ramos OL
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S76-8. PubMed ID: 1376843
[TBL] [Abstract][Full Text] [Related]
51. The effect of manidipine on renal hemodynamics in essential hypertensive patients: responses to acute stress.
Maki M; Kawamura H; Hara K; Mitsubayashi H; Suzuki K; Itou S; Usui W; Yasugi T
Blood Press Suppl; 1992; 3():106-13. PubMed ID: 1343277
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular effects of isradipine in essential hypertension.
Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
[TBL] [Abstract][Full Text] [Related]
53. Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations.
Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko MK; Wiesner RH; Krom RA
Am J Hypertens; 2000 Mar; 13(3):231-9. PubMed ID: 10777026
[TBL] [Abstract][Full Text] [Related]
54. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
Allikmets K; Parik T; Teesalu R
Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
[TBL] [Abstract][Full Text] [Related]
55. Renal effects of the new calcium channel blocking drug isradipine.
Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
[TBL] [Abstract][Full Text] [Related]
56. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients.
Takabatake T; Ohta H; Sasaki T; Satoh S; Ohta K; Ise T; Kobayashi K
Eur J Clin Pharmacol; 1993; 45(4):321-5. PubMed ID: 8299663
[TBL] [Abstract][Full Text] [Related]
57. Calcium-channel entry blocker therapy for hypertensive patients with concomitant renal impairment: a focus on isradipine.
Frishman WH
J Clin Pharmacol; 1994 Dec; 34(12):1164-72. PubMed ID: 7738211
[TBL] [Abstract][Full Text] [Related]
58. Postexercise reflex control of forearm vascular resistance during calcium antagonism with slow-release oral isradipine.
Cléroux J; Kouamé N; Yardley C; Marshall A; Lacourcière Y
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S66-9. PubMed ID: 1376840
[TBL] [Abstract][Full Text] [Related]
59. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise.
Cléroux J; Yardley C; Marshall A; Coulombe D; Lacourcière Y
Am J Hypertens; 1992 Feb; 5(2):84-7. PubMed ID: 1532316
[TBL] [Abstract][Full Text] [Related]
60. Isradipine improves platelet function in hypertensives.
Sinzinger H; Virgolini I; Rauscha F; Fitscha P; O'Grady J
Eur J Clin Pharmacol; 1992; 42(1):43-6. PubMed ID: 1531796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
